A Phase I, Open-label, Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Subjects
Latest Information Update: 18 Oct 2019
At a glance
- Drugs Milategrast (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors EA Pharma
Most Recent Events
- 05 Sep 2019 Status changed to completed.
- 26 Feb 2018 New trial record